Structure-activity relationships for organometallic osmium arene phenylazopyridine complexes with potent anticancer activity.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Dalton Transactions

• Publication date

  2011-10-05

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/c1dt10937ePMID 21860862
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• I and J

  2012influential reference
• Anti-colorectal cancer activity of an organometallic osmium arene azopyridine complex

  2011cited by this paper
• Osmium(VI) complexes as a new class of potential anti-cancer agents.

  2011cited by this paper
• Organometallic osmium arene complexes with potent cancer cell cytotoxicity.

  2010cited by this paper
• Cytotoxicity, hydrophobicity, uptake, and distribution of osmium(II) anticancer complexes in ovarian cancer cells.

  2010cited by this paper
• Organometallic Anticancer Compounds

  2010cited by this paper
• Ruthenium− and Osmium−Arene Complexes of 2-Substituted Indolo[3,2-c]quinolines: Synthesis, Structure, Spectroscopic Properties, and Antiproliferative Activity

  2010cited by this paper
• In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model.

  2010cited by this paper
• Osmium(II)--versus ruthenium(II)--arene carbohydrate-based anticancer compounds: similarities and differences.

  2010cited by this paper
• Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

  2009cited by this paper
• Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.

  2009cited by this paper
• Arene control over thiolate to sulfinate oxidation in albumin by organometallic ruthenium anticancer complexes.

  2009cited by this paper
• Use of Reduced Graphs To Encode Bioisosterism for Similarity-Based Virtual Screening

  2009cited by this paper
• Bioorganometallic chemistry--from teaching paradigms to medicinal applications.

  2009cited by this paper
• Osmium carbonyl clusters containing labile ligands hyperstabilize microtubules.

  2009cited by this paper
• Catalytic organometallic anticancer complexes

  2008cited by this paper
• Similar biological activities of two isostructural ruthenium and osmium complexes.

  2008cited by this paper
• Cytoplasmic initiation of cisplatin cytotoxicity.

  2008cited by this paper
• Osmium Carbonyl Clusters: A New Class of Apoptosis Inducing Agents

  2008cited by this paper
• Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents.

  2008cited by this paper
• Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and antiproliferative activity.

  2007cited by this paper
• Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity.

  2007cited by this paper
• Osmium NAMI-A analogues: synthesis, structural and spectroscopic characterization, and antiproliferative properties.

  2007cited by this paper
• Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.

  2007cited by this paper
• Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.

  2006cited by this paper
• Sulforhodamine B colorimetric assay for cytotoxicity screening

  2006cited by this paper
• In Vitro Evaluation of Rhodium and Osmium RAPTA Analogues: The Case for Organometallic Anticancer Drugs Not Based on Ruthenium

  2006cited by this paper
• In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.

  2005cited by this paper
• Fluorescence probes used for detection of reactive oxygen species.

  2005cited by this paper
• Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine

  2004cited by this paper
• Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

  2004cited by this paper
• Γ and B

  2004cited by this paper
• DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.

  2003cited by this paper
• Interactions with aromatic rings in chemical and biological recognition.

  2003cited by this paper
• Cisplatin: mode of cytotoxic action and molecular basis of resistance

  2003cited by this paper
• Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.

  2002cited by this paper
• Molecular properties that influence the oral bioavailability of drug candidates.

  2002cited by this paper
• In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer

  2002cited by this paper
• Calculation of the hydrophobicity of platinum drugs.

  2001cited by this paper
• Inhibition of cancer cell growth by ruthenium(II) arene complexes.

  2001cited by this paper
• Role of lipophilicity in determining cellular uptake and antitumour activity of gold phosphine complexes

  2000cited by this paper
• Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

  1999cited by this paper
• Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader.

  1999cited by this paper
• Bioisosterism: A Rational Approach in Drug Design.

  1996cited by this paper
• Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione.

  1994cited by this paper
• Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.

  1993cited by this paper
• An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivities to antitumour agents shown by a range of human tumour cell lines.

  1990cited by this paper
• Phase annealing in SHELX-90: direct methods for larger structures

  1990cited by this paper
• The nature of .pi.-.pi. interactions

  1990cited by this paper
• The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid.

  1989cited by this paper
• Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.

  1987cited by this paper
• Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.

  1985cited by this paper
• A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry.

  1981cited by this paper
• Intra-articular osmic acid in rheumatoid arthritis: five years' experience.

  1980cited by this paper
• Is there a place for chemical and radiation synovectomy in rheumatic diseases?

  1979cited by this paper
• Changes in muscle fibre size and physical performance in patients with rheumatoid arthritis after short-term physical training.

  1976cited by this paper
• Platinum Compounds: a New Class of Potent Antitumour Agents

  1969cited by this paper
• A and V

  1962cited by this paper
• Cáncer

  1939cited by this paper
• and as an in

  year unknowncited by this paper

• Photodynamic therapeutic potential and challenges of platinum group metal complexes in cancer treatment

  2025cites this paper
• Partial to Total Generation of 3D Transition-Metal Complexes

  2024cites this paper
• 187Os nuclear resonance scattering to explore hyperfine interactions and lattice dynamics for biological applications

  2024cites this paper
• A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies.

  2024cites this paper
• Anticancer Properties of Ru and Os Half-Sandwich Complexes of N,S Bidentate Schiff Base Ligands Derived from Phenylthiocarbamide.

  2023cites this paper
• Impact of Coordination Mode and Ferrocene Functionalization on the Anticancer Activity of N-Heterocyclic Carbene Half-Sandwich Complexes.

  2022cites this paper
• Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms

  2022cites this paper
• Organometallic Chemistry of Anticancer Ruthenium and Osmium Complexes

  2021cites this paper
• Arene-ruthenium(II) complexes with pyrazole-based ligands bearing a pyridine moiety: Synthesis, structure, DFT calculations, and cytotoxicity

  2021cites this paper
• Osmium–arene complexes with high potency towards Mycobacterium tuberculosis

  2021cites this paper
• Triazolyl‐Functionalized N‐Heterocyclic Carbene Half‐Sandwich Compounds: Coordination Mode, Reactivity and in vitro Anticancer Activity

  2021cites this paper
• Intracellular Photophysics of an Osmium Complex bearing an Oligothiophene Extended Ligand

  2020cites this paper
• Antimicrobial, antioxidant and antitumor activities of Nano‐Structure Eu (III) and La (III) complexes with nitrogen donor tridentate ligands

  2020cites this paper
• Thiourea-Derived Chelating Ligands and Their Organometallic Compounds: Investigations into Their Anticancer Activity

  2020cites this paper
• Structure-activity relationships for osmium(II) arene phenylazopyridine anticancer complexes functionalised with alkoxy and glycolic substituents.

  2020cites this paper
• Dose- and time-dependent tolerability and efficacy of organo-osmium complex FY26 and its tissue pharmacokinetics in hepatocarcinoma-bearing mice

  2020cites this paper
• Study of the anticancer properties of optically active titanocene oximato compounds

  2019cites this paper
• Novel osmium(ii)–cymene complexes containing curcumin and bisdemethoxycurcumin ligands

  2019cites this paper
• Hydroxyquinoline-derived anticancer organometallics: Introduction of amphiphilic PTA as an ancillary ligand increases their aqueous solubility.

  2019cites this paper
• Mechanism of Action of Anticancer Metallodrugs

  2018cites this paper
• Organoruthenium and Organoosmium Complexes of 2-Pyridinecarbothioamides Functionalized with a Sulfonamide Motif: Synthesis, Cytotoxicity and Biomolecule Interactions.

  2018cites this paper
• The Anticancer Activities of Some Nitrogen Donor Ligands Containing bis-Pyrazole, Bipyridine, and Phenanthroline Moiety Using Docking Methods

  2018cites this paper
• Future potential of osmium complexes as anticancer drug candidates, photosensitizers and organelle-targeted probes.

  2018cites this paper
• The Intriguing Potential of “Minor” Noble Metals: Emerging Trends and New Applications

  2018cites this paper
• Half-sandwich complexes of platinum group metals (Ir, Rh, Ru and Os) and some recent biological and catalytic applications

  2018cites this paper
• Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development.

  2018cites this paper
• Biological evaluation of water soluble arene Ru(II) enantiomers with amino-oxime ligands.

  2018cites this paper
• Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action.

  2018cites this paper
• Molecular electrochemistry: A central method to understand the metabolic activation of therapeutic agents. The example of metallocifen anti-cancer drug candidates

  2017cites this paper
• Anti-Inflammatory Oxicams as Multi-donor Ligand Systems: pH- and Solvent-Dependent Coordination Modes of Meloxicam and Piroxicam to Ru and Os.

  2017cites this paper
• Anticancer activity of hydroxy- and sulfonamide-azobenzene platinum(II) complexes in cisplatin-resistant ovarian cancer cells.

  2017cites this paper
• Reprint of "Anticancer activity of hydroxy- and sulfonamide-azobenzene platinum(II) complexes in cisplatin-resistant ovarian cancer cells".

  2017cites this paper
• Halide Control of N,N-Coordination versus N,C-Cyclometalation and Stereospecific Phenyl Ring Deuteration of Osmium(II) p-Cymene Phenylazobenzothiazole Complexes

  2017cites this paper
• Redox‐Active Metal Complexes for Anticancer Therapy

  2017cites this paper
• Ruthenium(II) bipyridine complexes: from synthesis and crystal structures to electrochemical and cytotoxicity investigation

  2017cites this paper
• SYNTHESIS , PHYSICO-CHEMICAL AND ANTIMICROBIAL PROPERTIES OF SOME METAL ( II )-MIXED LIGAND COMPLEXES OF TRIDENTATE SCHIFF BASE DERIVES FROM Β-LACTAM ANTIBIOTIC { ( CEPHALEXIN MONO HYDRATE )-4-CHLOROBENZOPHENONE } AND SACCHARIN Taghreed

  2017cites this paper
• Half-sandwich late transition metal complexes based on functionalized carborane ligands

  2016cites this paper
• Photophysical and Biological Studies with Organometallic Ruthenium Complexes of Selenodiazole Ligands

  2016cites this paper
• Arene ruthenium(II) complexes with chalcone, aminoantipyrine and aminopyrimidine based ligands: synthesis, structure and preliminary evaluation of anti-leukemia activity

  2016cites this paper
• Osmocenyl-tamoxifen derivatives target the thioredoxin system leading to a redox imbalance in Jurkat cells.

  2016cites this paper
• Anticancer activity of Ru- and Os(arene) compounds of a maleimide-functionalized bioactive pyridinecarbothioamide ligand.

  2016cites this paper
• SYNTHESIS AND MOLECULAR DOCKING STUDY OF NOVEL COMPOUND

  2016cites this paper
• Photophysical and Biological Studies with Organometallic Ruthenium Complexes of Selenodiazole Ligands

  2016cites this paper
• Noble metals in medicine: Latest advances

  2015cites this paper
• Synthesis, DNA binding and docking studies of copper(II) complexes containing modified phenanthroline ligands

  2015cites this paper
• Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells

  2015influential citation
• Anticancer Organometallic Osmium(II)‐p‐cymene Complexes

  2015cites this paper
• Antimalarial activity of ruthenium(II) and osmium(II) arene complexes with mono- and bidentate chloroquine analogue ligands.

  2015cites this paper
• DFT Investigation of the Mechanism of Action of Organoiridium(III) Complexes As Anticancer Agents.

  2015cites this paper
• Synthesis, Characterization, and Biological Properties of Osmium-Based Tamoxifen Derivatives - Comparison with Their Homologues in the Iron and Ruthenium Series: Osmium-Based Tamoxifen Derivatives

  2015cites this paper
• Development of ruthenium-based complexes as anticancer agents: toward a rational design of alternative receptor targets

  2015cites this paper
• Neutral and cationic osmium(II)-arene metallodendrimers: Synthesis, characterisation and anticancer activity

  2014cites this paper
• The Spectroscopic and Conductive Properties of Ru(II) Complexes with Potential Anticancer Properties

  2014cites this paper
• Synthesis, Physico-Chemical and Antimicrobial Properties of Some Metal (II) -Mixed Ligand Complexes of Tridentate Schiff Base Derives From Β-Lactam Antibiotic {(Cephalexin Mono Hydrate)-4-Chlorobenzophenone} and Saccharin

  2014cites this paper
• Potent organometallic osmium compounds induce mitochondria-mediated apoptosis and S-phase cell cycle arrest in A549 non-small cell lung cancer cells.

  2014cites this paper
• Development of anticancer agents: wizardry with osmium.

  2014cites this paper
• Metal–DNA Coordination Complexes

  2013cites this paper
• Mirror-Image Organometallic Osmium Arene Iminopyridine Halido Complexes Exhibit Similar Potent Anticancer Activity

  2013cites this paper
• Novel metal(II) arene 2-pyridinecarbothioamides: a rationale to orally active organometallic anticancer agents

  2013cites this paper
• Organometallic Iridium(III) Anticancer Complexes with New Mechanisms of Action: NCI-60 Screening, Mitochondrial Targeting, and Apoptosis

  2013cites this paper
• Bidentate ligands on osmium(VI) nitrido complexes control intracellular targeting and cell death pathways.

  2013cites this paper
• Méthodes et compositions pour le traitement de cancer

  2013cites this paper
• Osmium Complexes with Azole Heterocycles as Potential Antitumor Drugs

  2013cites this paper
• Exploration of the medical periodic table: towards new targets.

  2013cites this paper
• Designing organometallic compounds for catalysis and therapy.

  2012cites this paper
• Challenges and Opportunities in the Development of Organometallic Anticancer Drugs

  2012cites this paper
• Cellular uptake and remarkable photocytotoxicity of pyrenylter pyridine oxovanadium(IV) complexes of dipyridophenazine bases

  2012cites this paper
• Encapsulation of inorganic and organic guest molecules into an organometallic hexacationic arene osmium metalla-prism: Synthesis, characterisation and anticancer activity

  2012cites this paper
• Osmium(VI) nitrido complexes bearing azole heterocycles: a new class of antitumor agents

  2012cites this paper
• Fast and slow versus strong and weak metal-DNA binding: consequences for anti-cancer activity.

  2012cites this paper
• The contrasting chemical reactivity of potent isoelectronic iminopyridine and azopyridine osmium(II) arene anticancer complexes

  2012cites this paper
• Ruthenium- and osmium-arene complexes of 8-substituted indolo[3,2-c]quinolines: Synthesis, X-ray diffraction structures, spectroscopic properties, and antiproliferative activity

  2012cites this paper
• Reactions of an osmium-hexahydride complex with cytosine, deoxycytidine, and cytidine: the importance of the minor tautomers.

  2012cites this paper
• N-h and N-C bond activation of pyrimidinic nucleobases and nucleosides promoted by an osmium polyhydride.

  2012cites this paper
• Dicarba-closo-dodecarborane-containing half-sandwich complexes of ruthenium, osmium, rhodium and iridium: biological relevance and synthetic strategies.

  2012cites this paper